Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health

Obesity, type 2 diabetes (T2DM), hypertension (HTN), and Cardiovascular Disease (CVD) often cluster together as “Cardiometabolic Disease” (CMD). Just under 50% of patients with CMD increased the risk of morbidity and mortality right from the beginning of the COVID-19 pandemic as it has been reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo Presti, Elena, Nuzzo, Domenico, Al Mahmeed, Wael, Al-Rasadi, Khalid, Al-Alawi, Kamila, Banach, Maciej, Banerjee, Yajnavalka, Ceriello, Antonio, Cesur, Mustafa, Cosentino, Francesco, Firenze, Alberto, Galia, Massimo, Goh, Su-Yen, Janez, Andrej, Kalra, Sanjay, Kapoor, Nitin, Kempler, Peter, Lessan, Nader, Lotufo, Paulo, Papanas, Nikolaos, Rizvi, Ali A., Sahebkar, Amirhossein, Santos, Raul D., Stoian, Anca P., Toth, Peter P., Viswanathan, Vijay, Rizzo, Manfredi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510069/
https://www.ncbi.nlm.nih.gov/pubmed/36174875
http://dx.doi.org/10.1016/j.bbadis.2022.166559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510069/
https://www.ncbi.nlm.nih.gov/pubmed/36174875
http://dx.doi.org/10.1016/j.bbadis.2022.166559

Ejemplares similares